Glenmark Philippines. Inc. is a subsidiary of Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company. Glenmark is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast-growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 12,000 people in over 80 countries. It has fourteen manufacturing facilities in four countries and has five R&D centres.
Glenmark Philippines, Inc., began its operation in 2004 and is one of the known pharmaceutical companies in the country focusing on the areas of respiratory and dermatology, with over 30 products being marketed successfully. For almost 20 years of operating, Glenmark Philippines Inc., has already established a good relationship with the top doctors and key opinion leaders in the country.
Presently, Glenmark Philippines Inc., employs more than 20 professionals located in main office and almost 100 sales force covering the entire country.
At Glenmark, we believe in enriching lives and making a difference to patients all over the Philippines.